Level Chart

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Kalydeco Revenue is at a current level of 0.000, down from 112.40M last quarter and down from 125.00M one year ago. This is a change of -100.0% from last quarter and -100.0% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Mar 2024
Last Updated Jul 31 2024, 08:44 EDT
Average Growth Rate -40.27%
Value from Last Quarter 112.40M
Change from Last Quarter -100.0%
Value from 1 Year Ago 125.00M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
March 31, 2024 0.00
December 31, 2023 112.40M
September 30, 2023 112.80M
June 30, 2023 125.30M
March 31, 2023 125.00M
December 31, 2022 136.10M
September 30, 2022 139.40M
June 30, 2022 138.70M
March 31, 2022 139.00M
Date Value
December 31, 2021 152.00M
September 30, 2021 162.00M
June 30, 2021 183.00M
March 31, 2021 186.00M
December 31, 2020 193.00M
September 30, 2020 194.00M
June 30, 2020 203.00M
March 31, 2020 213.00M
December 31, 2019 236.00M

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Kalydeco Revenue is at a current level of 0.000, down from 112.40M last quarter and down from 125.00M one year ago. This is a change of -100.0% from last quarter and -100.0% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Mar 2024
Last Updated Jul 31 2024, 08:44 EDT
Average Growth Rate -40.27%
Value from Last Quarter 112.40M
Change from Last Quarter -100.0%
Value from 1 Year Ago 125.00M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
VRTX Vertex Pharmaceuticals Inc -4.63%